|
|
||||||||
Service de Génétique Appliquée, Centre de Recherches Industrielles, Université Libre de Bruxelles, 24 rue de l'Industrie, B-1400 Nivelles, Belgium
The gpII glycoprotein of varicella-zoster virus (VZV) was produced in CV1 cells via vaccinia virus recombinants. Two different DNA constructs were expressed: the first one encodes the complete gpII protein (gpII s+a+) and the second a truncated species lacking the membrane anchorage domain (gpII s+a-). To achieve expression both coding sequences had to be engineered at the 5' end by substituting the unusually short (24 bp) natural signal sequence by a more conventional one encoding 29 amino acids. Recombinant gpII proteins were detected in vaccinia virus-infected cells by ELISA and immunoprecipitation. Both forms of recombinant gpII proteins were produced as glycosylated single-chain molecules of respectively 110K and 90K. Upon reduction these were only partially converted into subunits. A rabbit infected with the vaccinia virus recombinant expressing the complete gpII produced antibodies which recognized VZV antigens and neutralized VZV infectivity in vitro, independent of complement.
Received 7 July 1992;
accepted 11 November 1992.
This article has been cited by other articles:
![]() |
L. Maresová, L. Kutinová, V. Ludvíková, R. Zák, M. Mares, and S. Nemecková Characterization of interaction of gH and gL glycoproteins of varicella-zoster virus: their processing and trafficking J. Gen. Virol., June 1, 2000; 81(6): 1545 - 1552. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |